Cefoperazone against carbenicillin- resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin
- 1 October 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 12 (4) , 337-345
- https://doi.org/10.1093/jac/12.4.337
Abstract
The in-vitro activities of cefoperazone, cefotaxime, ceftriaxone, latamoxef (moxa-lactam), ceftazidime and N-formimidoyl-thienamycin (N-f-thienamycin) were compared against clinical isolates of Pseudomonas aeruginosa that were resistant to carbenicillin and gentamicin, or against those which were susceptible. N-f-thienamycin and ceftazidime were more active than other cephalosporins against all Pseudomonas isolates. Cefoperazone was more active than cefotaxime, ceftriaxone and latamoxef only against carbenicillin-susceptible isolates: isolates resistant to carbenicillin exhibited markedly increased resistance to cefoperazone, but not to N-f-thienamycin or ceftazidime. A partial cross-resistance was observed between carbenicillin and cefoperazone. This was due to the presence in these Pseudomonas isolates of a plasmid-mediated β-lactamase which was active against carbenicillin and cefoperazone but not against cefotaxime, ceftriazone and latamoxef.Keywords
This publication has 4 references indexed in Scilit:
- In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their β-lactamasesJournal of Antimicrobial Chemotherapy, 1981
- Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillinJournal of Antimicrobial Chemotherapy, 1981
- Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibioticsAntimicrobial Agents and Chemotherapy, 1980
- GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 1980